our
company

Memic has set out to transform robot-assisted surgery, with proprietary technology that has the potential to far surpasses today’s best solutions. Providing unprecedented access and maneuverability, our Memic’s Hominis™ surgical platform features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360˚ articulation for various access configurations. Dramatically smaller, more versatile, and less costly than current robotic platforms, our technology opens up a host of minimally -invasive procedures that until now have been off-limits to robot-assisted surgery. Some pipeline indications include abdominal single and multi-port surgery, as well as procedures performed in a trans-oral approach. We envision a near future where numerous indications – and millions of patients – will benefit from these disruptive capabilities.

our people
  • Dvir Cohen CEO

    Dvir brings extensive experience in robotic, innovative, and challenging systems. Having led Memic from the inception of the idea, he brought the technology from academia to the tech incubator, performed comprehensive market research to identify an unmet clinical need for trans-vaginal approach to gynecology, and developed the early prototypes. Proving the feasibility of this unique approach, he then built a strong scientific team, moving from prototype to a product that was tested in animal models and cadaveric studies, and performing several multi-center clinical studies in gynecology.

    Previously, Dvir served in an elite group of the Ministry of Defense, leading R&D teams for precise motion systems and sub-micron accuracy robotic systems. In this capacity, he shepherded unique products from concept to prototyping and V&V, developing and implementing production lines for manufacturing and calibration.

    Dvir holds a B.Sc and M.Sc in mechanical engineering from the Technion’s Brakim excellence program, and an MBA in technology, innovation, and entrepreneurship from Recanati Business School. For his contribution to a high-end robotic device, he was recognized as an outstanding officer by the IDF’s Chief of General Staff.

    Hagai BerkovichCOO

    Hagai lead the company’s manufacturing lines analysis and scale up process.
    Hagai served as COO at Motorika, and former to that CEO at Tamuz F.T.K Solutions. Previous positions included Operation, Airborne Structure Director at Elbit Systems – Cyclone, Business Unit VP at Sanmina SCI – Israel Medical Systems. He holds MBA Tel-Aviv University; BSc Aeronautical Engineering Technion.

    Noam AtarCFO

    Noam leads the financial departments and wide strategic and operational initiatives.

    Noam served as senior director of finance & supply chain at Ferrings Pharmaceutical, co-founder & CEO of Rway Applications, controller of international operations at Radware and controller at Bio-Technology General Ltd.
    He holds a Bachelor of accounting and economics, Hebrew university and MBA from Recanati Business School, certified in business analytics from Harvard Business School Online

    Limor KuznitzVP Clinical Affairs

    Limor lead the clinical development and established the post-market study to support the company’s soft launch.

    Limor served as clinical trial manager at BlueWind Medical, clinical research associate at Gardia Medical and clinical applications specialist at IceCure Medical
    She holds a B. Sc in Biomedical Engineering, Tel Aviv university and certified as CRA for monitoring and coordinating clinical trials by Bioforum Ltd.

    Yaron Levinson VP R&D

    Yaron lead the development of the Hominis System from the technological incubator to a fully operated surgical system.

    Yaron served as system and Control manager at Medical Surgery Technologies (MST) and Founder & CEO of Paragon Measure Inc.

    He holds a B. Sc and M.Sc in Mechanical Engineering, BGU, Ph.D in Control, Signal Processing and Optimization, the Technion, Start-up Postdoc at Runway, Mobile Health and Machine Learning, Cornell Tech.

    Steven NunesVP Sales

    Steve lead the sales activities and strategic relationships with potential clients.

    Steve served as Sr. VP sales at Mako, VP sales at Visualization Technology, Sr. VP Sales at OMNI Life Science and distributor at Richard Wolf Gynecology specialty.

    He holds a B. Sc and M.Sc in Mechanical Engineering, BGU, Ph.D in Control, Signal Processing and Optimization, the Technion, Start-up Postdoc at Runway, Mobile Health and Machine Learning, Cornell Tech.

    Sheryl SabbanVP IP

    Sheryl lead the intellectual property department and established a robust IP portfolio and strategy.

    Sheryl served as IP director at Teva’s innovation division and senior patent manager at Teva’s generic division, in charge of global strategy for commercialization.

    She holds a B.Sc in Biology and M.Sc in Medical Science from the Hebrew university

    Einav Yemini VP QA & RA

    Einav lead the regulatory department and established a robust regulatory process together with the FDA for a De Novo pathway.

    Einav served as the Regulatory associate at Intuitive Surgical. she brings Extensive experience with Single-Port robotic Instruments, multiple submissions of 510(k) files to the FDA and as RA, Design and Specification engineer at IVT Medical.

    She holds a B.Sc in Biomedical Engineering, Tel Aviv University and served as Research Assistance at the Neurogenomics Lab, Sheba Medical Center.

  • Maurice Ferre Chairman of the Board

    Maurice R. Ferré MD is INSIGHTEC’S CEO and chairman of the board of directors. He brings over 20 years of experience in the medical device industry. Before INSIGHTEC, Dr. Ferré served as chairman of the board and CEO of MAKO Surgical Corp., a transformational robotic surgical company that he co-founded in 2004. The company was IPO’d in 2008 and sold to Stryker Corp. for $1.65 billion in 2013. Prior to MAKO, Dr. Ferré was founder, CEO, and president of Visualization Technology, Inc., which became the world leader in image-guided surgery for ENT, cranial, and orthopedic procedures. The company was acquired by GE Healthcare in 2002.
    Dr. Ferré earned his Doctor of Medicine and Master of Public Health degress from Boston University. He received the prestigious Ernest & Young 2007 Entrepreneur of the Year Award. He is currently active on the boards of Advamed, the Everglades Foundation, and Boston University.

    About INSIGHTEC: the company’s MR-guided focused ultrasound technology allows to perform procedures with surgical precision but without incisions, thus transforming the standard of care. The company’s non-invasive Exablate and Exablate Neuro platforms are clinically proven for treating essential tremor, painful bone metastases, and uterine fibroids. INSIGHTEC continuously invests in and expanding its current and investigational applications.

    Eyal Lifschitz Chairman of Board's Business Committee

    Eyal Lifschitz is CEO, general partner, and co-founder of Peregrine Ventures.
    Prior to founding Peregrine, Eyal co-founded and led the business development efforts of multiple medical technology companies, including PharmaSys (acquired by Elan Corp. NYSE:ELN), ECR (acquired by AVX Corp. NYSE:AVX), Visioncare Ophthalmic Technologies, and BioControl Ltd. From 2003-2007, Eyal also served as a director of Given Imaging (NASDAQ: GIVN).

    Peregrine is an Israeli venture capital fund, with a focus on medical devices and an impressive record of founding, managing, and promoting Israeli hi-tech companies. Peregrine enjoys a wide network of contacts, and is supported by a investment committee and advisory board consisting of expert teams specializing in all applicable disciplines. The fund has invested in and initiated some of Israel’s leading medical companies, including Neovasc, B-Balloon, Valtech, Eximo, Memic, and Cordio.

    Lior Shahory Board Member

    Lior brings extensive experience in investment due diligence, strategic planning, project management, and business development. He works closely with entrepreneurs to establish successful companies.
    Lior serves as CEO of Incentive, Peregrine’s technology incubator. Under his leadership, Incentive has received seven excellence awards from the State of Israel.
    Prior to Peregrine, Lior served as deputy director of the Israel Chief Scientist’s incubator program.
    Lior holds a BA in economics and business management from the University of Haifa, and an MBA from Tel Aviv University.

    Dr. Irit Yaniv M.D., MBA Board Member

    Dr. Irit Yaniv is a seasoned medtech executive, and has held CEO positions at medical device companies Impulse Dynamics and MetaCure.
    Dr. Yaniv plays a key role in leading Accelmed’s early-stage portfolio companies, serving either as chairperson or as an active board member.
    Dr. Yaniv holds an MD degree from Ben Gurion University, and an MBA from the Recanati Business School at Tel Aviv University.

    Accelmed is an investment firm focused on creating value for medical device companies and technologies. Founded by Mori Arkin and Uri Geiger. It invests in small and mid-cap private and public companies. A successful advocate of the platform model with a proven track record, Accelmed boasts a large team of accomplished investment professionals. Its vision is to create leading med-tech players by merging commercial platforms with small innovative growth companies, predominantly from Israel.

    Yigal Cohen Orgad Board Member

    Mr. Cohen-Orgad has served as Israel’s Minister of Finance, as a director of Bezeq Israel Telecommunication Corp., and as a director of Israel Electric Corporation. He is Chancellor of Ariel University, and sits on the board of Ariel University’s R&D company.

    Ariel Scientific Innovations is a leading technology transfer company committed to transforming Ariel University (AU) technologies into products with a positive impact on society.
    Ariel Scientific Innovations acts as a professional partner to AU researchers, by identifying innovations, patenting inventions, supporting applied research, and commercializing the results to selected commercial partners.

    Dr. Israel Frieder Board Member

    Dr. Israel Frieder serves Ltd., as chairman at AA Pearl Investments, Ltd., as chairman at ETV Energy, Ltd., and as chairman at Ariel Scientific Innovations Ltd.
    He has served on the board of directors at RR Media, at Cellvine Ltd., and at RiT Technologies Ltd.
    He received his graduate degree from the Technion, an MBA from the Hebrew University of Jerusalem, and a doctorate degree from Bar-Ilan University.

    Dr. Morry Blumenfeld Board Observer

    Dr. Morry Blumenfeld is president and CEO of medical device consulting company Quescon Consultants, Ltd., and a partner at Meditech Advisors, LLC. He was an executive at GE for nearly 35 years, and served GE Medical Systems Business in numerous roles, including initiating both the CT and MRI businesses, and as managing director of GE Medical Systems in Israel.
    Morry holds five patents, and serves or has served on the boards of a number of medical device and technology companies in the USA and Israel – as well as numerous Canadian, international, and Israeli advisory boards in technology and science. He is on the board of the Hebrew University and Yissum (the Hebrew University’s tech transfer company), and on the scientific advisory board of the Momentum Fund of Ramot (Tel Aviv University’s tech transfer company).
    Dr. Blumenfeld received his undergraduate degree and Ph.D from the University of Toronto.

    Guy ShamirBoard Observer

    Mr. Guy Shamir has served as business development manager at Mivtach Shamir Holdings, Ltd. since 2011.
    He previously served as a director at Tefron, Ltd., and as a director at Manif Financial Services, Ltd.
    He holds a degree in business administration from the Interdisciplinary Center in Herzliya.

    Mivtach Shamir Holdings is an investment company based in Israel, led by Israeli investor Meir Shamir. Mivtach Shamir invests in three sectors: technology and communications, industrial investments, and real estate. Shares of Mivtach Shamir are traded on the Tel Aviv Stock Exchange (TASE: MISH).

back to top
think nimble

think nimble

hominis™
think boundless

think boundless

clinical spectrum
think forward

think forward

news & events
think together

think together

contact us